Related Experiment Videos
Transcription-modulating drugs: mechanism and selectivity
W Cai1, L Hu, J G Foulkes
1Oncogene Science Inc, 106 Charles Lindbergh Boulevard, Uniondale, NY 11553, USA. wcai@oncogene.com
Current Opinion in Biotechnology
|December 1, 1996
Summary
This study reviews transcription-modulating drugs, including immunosuppressants, estrogen analogs, antidiabetics, and anti-inflammatories. Understanding their molecular mechanisms enhances drug selectivity and reduces toxicity.
Area of Science:
- Pharmacology
- Molecular Biology
- Drug Discovery
Background:
- Transcription-modulating drugs are key therapeutics.
- Understanding their selectivity is crucial for improved efficacy and safety.
Purpose of the Study:
- To review the molecular mechanisms of four drug classes: immunosuppressants, estrogen analogs, thiazolidinediones, and salicylates.
- To explore how these drugs modulate gene transcription and achieve therapeutic effects.
Main Methods:
- Review of existing literature on drug mechanisms.
- Analysis of how specific drugs (cyclosporin A, FK506, rapamycin, tamoxifen, rolaxifene, thiazolidinediones, salicylates) interact with molecular targets.
Main Results:
- Immunosuppressants inhibit interleukin-2 or p70(s6k) activation.
- Estrogen analogs modulate gene expression via estrogen receptor functions.
- Thiazolidinediones activate PPARγ and suppress TNF-α effects.
- Salicylates inhibit NFκB transcription factor.
Conclusions:
- Detailed understanding of drug mechanisms aids in identifying better drug targets.
- Insights gained can guide the development of future transcription-modulating drugs with enhanced selectivity and reduced toxicity.